Genome-wide association study of the plasma triglyceride response to an n-3 polyunsaturated fatty acid supplementation

Journal of Lipid Research

Volumn 55, Issue 7, 2014, Pages 1245-1253

  Rudkowska, Iwona ^a,c   Guénard, Frédéric ^a,c   Julien, Pierre ^c   Couture, Patrick ^a   Lemieux, Simone ^a   Barbier, Olivier ^b,c,d   Calder, Philip C ^e,f,g   Minihane, Anne Marie ^h   Vohl, Marie Claude ^a,c  

^a UNIVERSITÉ LAVAL   (Canada)

^b Endocrinology and Nephrology   (Canada)

^c Laboratory of Molecular Pharmacology   (Canada)

^d University Laval   (Canada)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^f UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^g KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^h UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Fi sh oil; Genetic risk score; Nutrigenetics; Responders; Single nucleotide polymorphism

Indexed keywords

GENOMIC DNA; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; INTRON; IQCJ SCHIP1 GENE; MALE; MYB GENE; NELL1 GENE; NORMAL HUMAN; NUTRIGENOMICS; NXPH1 GENE; PHF17 GENE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SLIT2 GENE; SUPPLEMENTATION; ADULT; BLOOD; CLINICAL TRIAL; DIETARY SUPPLEMENT; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MULTICENTER STUDY; RISK FACTOR;

ADULT; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TRIGLYCERIDES;

EID: 84903934773     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M045898     Document Type: Article

References (33)

1. Harris, W. S. 1997. n-3 fatty acids and serum lipoproteins: human studies. Am. J. Clin. Nutr. 65: 1645S-1654S.
2. Hartweg, J., R. Perera, V. Montori, S. Dinneen, H. A. Neil, and A. Farmer. 2008. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst. Rev. CD003205.
3. Madden, J., C. M. Williams, P. C. Calder, G. Lietz, E. A. Miles, H. Cordell, J. C. Mathers, and A. M. Minihane. 2011. The impact of common gene variants on the response of biomarkers of cardiovascular disease (CVD) risk to increased fi sh oil fatty acids intakes. Annu. Rev. Nutr. 31: 203-234.
4. Caslake, M. J., E. A. Miles, B. M. Kofl er, G. Lietz, P. Curtis, C. K. Armah, A. C. Kimber, J. P. Grew, L. Farrell, J. Stannard, et al. 2008. Effect of sex and genotype on cardiovascular biomarker response to fi sh oils: the FINGEN Study. Am. J. Clin. Nutr. 88: 618-629.
5. Cormier, H., I. Rudkowska, A. M. Paradis, E. Thifault, V. Garneau, S. Lemieux, P. Couture, and M. C. Vohl. 2012. Association between polymorphisms in the fatty acid desaturase gene cluster and the plasma triacylglycerol response to an n-3 PUFA supplementation. Nutrients. 4: 1026-1041.
6. Rudkowska, I., A. M. Paradis, E. Thifault, P. Julien, O. Barbier, P. Couture, S. Lemieux, and M. C. Vohl. 2013. Differences in metabolomic and transcriptomic profiles between responders and non-responders to an n-3 polyunsaturated fatty acids (PUFAs) supplementation. Genes Nutr. 8: 411-423.
7. Minihane, A. M., S. Khan, E. C. Leigh-Firbank, P. Talmud, J. W. Wright, M. C. Murphy, B. A. Griffin, and C. M. Williams. 2000. ApoE polymorphism and fi sh oil supplementation in subjects with an atherogenic lipoprotein phenotype. Arterioscler. Thromb. Vasc. Biol. 20: 1990-1997.
8. Olano-Martin, E., E. Anil, M. J. Caslake, C. J. Packard, D. Bedford, G. Stewart, D. Peiris, C. M. Williams, and A. M. Minihane. 2010. Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL-cholesterol response to fi sh oil. Atherosclerosis. 209: 104-110.
9. Thifault, E., H. Cormier, A. Bouchard-Mercier, I. Rudkowska, A. M. Paradis, V. Garneau, C. Ouellette, S. Lemieux, P. Couture, and M. C. Vohl. 2013. Effects of age, sex, body mass index and APOE genotype on cardiovascular biomarker response to an n-3 polyunsaturated fatty acid supplementation. J. Nutrigenet. Nutrigenomics. 6: 73-82.
10. Tai, E. S., D. Corella, S. Demissie, L. A. Cupples, O. Coltell, E. J. Schaefer, K. L. Tucker, and J. M. Ordovas. 2005. Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the Framingham Heart Study. J. Nutr. 135: 397-403.
11. Lindi, V., U. Schwab, A. Louheranta, M. Laakso, B. Vessby, K. Hermansen, L. Storlien, G. Riccardi, and A. Rivellese. 2003. Impact of the Pro12Ala polymorphism of the PPAR-gamma2 gene on serum triacylglycerol response to n-3 fatty acid supplementation. Mol. Genet. Metab. 79: 52-60.
12. Burstein, M., and J. Samaille. 1960. On a rapid determination of the cholesterol bound to the serum alpha-and beta-lipoproteins. [Article in French] Clin. Chim. Acta. 5: 609.
13. Albers, J. J., G. R. Warnick, D. Wiebe, P. King, P. Steiner, L. Smith, C. Breckenridge, A. Chow, K. Kuba, S. Weidman, et al. 1978. Multilaboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein. Clin. Chem. 24: 853-856.
14. Friedewald, W. T., R. I. Levy, and D. S. Fredrickson. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
15. Desbuquois, B., and G. D. Aurbach. 1971. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J. Clin. Endocrinol. Metab. 33: 732-738.
16. Richterich, R., and H. Dauwalder. 1971. Determination of plasma glucose by hexokinase-glucose-6-phosphate dehydrogenase method. Schweiz. Med. Wochenschr. 101: 615-618.
17. Laurell, C. B. 1966. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal. Biochem. 15: 45-52.
18. Pirro, M., J. Bergeron, G. R. Dagenais, P. M. Bernard, B. Cantin, J. P. Despres, and B. Lamarche. 2001. Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men. Arch. Intern. Med. 161: 2474-2480.
19. Shaikh, N. A., and E. Downar. 1981. Time course of changes in porcine myocardial phospholipid levels during ischemia. A reassessment of the lysolipid hypothesis. Circ. Res. 49: 316-325.
20. Kröger, E., R. Verreault, P. H. Carmichael, J. Lindsay, P. Julien, E. Dewailly, P. Ayotte, and D. Laurin. 2009. Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging. Am. J. Clin. Nutr. 90: 184-192.
21. Nicodemus, K. K., W. Liu, G. A. Chase, Y. Y. Tsai, and M. D. Fallin. 2005. Comparison of type I error for multiple test corrections in large single-nucleotide polymorphism studies using principal components versus haplotype blocking algorithms. BMC Genet. 6 ( Suppl. 1 ): S78.
22. Duggal, P., E. M. Gillanders, T. N. Holmes, and J. E. Bailey-Wilson. 2008. Establishing an adjusted p-value threshold to control the family-wide type 1 error in genome wide association studies. BMC Genomics. 9: 516.
23. Del-Aguila, J. L., A. L. Beitelshees, R. M. Cooper-Dehoff, A. B. Chapman, J. G. Gums, K. Bailey, Y. Gong, S. T. Turner, J. A. Johnson, and E. Boerwinkle. 2014. Genome-wide association analyses suggest NELL1 infl uences adverse metabolic response to HCTZ in African Americans. Pharmacogenomics J. 14: 35-40.
24. Kraja, A. T., I. B. Borecki, M. Y. Tsai, J. M. Ordovas, P. N. Hopkins, C. Q. Lai, A. C. Frazier-Wood, R. J. Straka, J. E. Hixson, M. A. Province, et al. 2013. Genetic analysis of 16 NMR-lipoprotein fractions in humans, the GOLDN study. Lipids. 48: 155-165.
25. Qi, K., C. Fan, J. Jiang, H. Zhu, H. Jiao, Q. Meng, and R. J. Deckelbaum. 2008. Omega-3 fatty acid containing diets decrease plasma triglyceride concentrations in mice by reducing endogenous triglyceride synthesis and enhancing the blood clearance of triglyceride-rich particles. Clin. Nutr. 27: 424-430.
26. Wong, A. T., D. C. Chan, E. M. Ooi, T. W. Ng, G. F. Watts, and P. H. Barrett. 2013. Omega-3 fatty acid ethyl ester supplementation decreases very-low-density lipoprotein triacylglycerol secretion in obese men. Clin. Sci. (Lond. ). 125: 45-51.
27. Meĺn, E., B. E. Himes, J. M. Brehm, N. Boutaoui, B. J. Klanderman, J. S. Sylvia, and J. Lasky-Su. 2010. Analyses of shared genetic factors between asthma and obesity in children. J. Allergy Clin. Immunol. 126: 631-637.
28. Lee, Y. H., S. Nair, E. Rousseau, D. B. Allison, G. P. Page, P. A. Tataranni, C. Bogardus, and P. A. Permana. 2005. Microarray profi ling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of infl ammationrelated genes. Diabetologia. 48: 1776-1783.
29. Rudkowska, I., M. Verreault, O. Barbier, and M. C. Vohl. 2009. Differences in transcriptional activation by the two allelic (L162V Polymorphic) variants of PPARalpha after omega-3 fatty acids treatment. PPAR Res. 2009: 369602.
30. Hannun, Y. A., and L. M. Obeid. 2002. The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J. Biol. Chem. 277: 25847-25850.
31. Haus, J. M., S. R. Kashyap, T. Kasumov, R. Zhang, K. R. Kelly, R. A. Defronzo, and J. P. Kirwan. 2009. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes. 58: 337-343.
32. Qi, Q., A. Y. Chu, J. H. Kang, J. Huang, L. M. Rose, M. K. Jensen, L. Liang, G. C. Curhan, L. R. Pasquale, J. L. Wiggs, et al. 2014. Fried food consumption, genetic risk, and body mass index: gene-diet interaction analysis in three US cohort studies. BMJ. 348: g1610.
33. Speliotes, E. K., C. J. Willer, S. I. Berndt, K. L. Monda, G. Thorleifsson, A. U. Jackson, A. H. Lango, C. M. Lindgren, J. Luan, R. Mägi, et al. 2010. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat. Genet. 42: 937-948.